SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbla... von Ben-Josef, Edgar, Guthrie, Katherine A, El-Khoueiry, Anthony B, Corless, Christopher L, Zalupski, Mark M, Lowy, Andrew M, Thomas, Jr, Charles R, Alberts, Steven R, Dawson, Laura A, Micetich, Kenneth C, Thomas, Melanie B, Siegel, Abby B, Blanke, Charles D

Volltext

Serum Antioxidant Nutrients, Vitamin A, and Mortality in U.S. Adults von GOYAL, Abhishek, TERRY, Mary Beth, SIEGEL, Abby B

Volltext

Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker von JING SHEN, ANTAI WANG, QIAO WANG, GURVICH, Irina, SIEGEL, Abby B, REMOTTI, Helen, SANTELLA, Regina M

Volltext

HER2/neu-directed therapy for biliary tract cancer von Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C, Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A, Kaseb, Ahmed O, Thomas, Melanie B, Siegel, Abby B

Volltext

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma von SIEGEL, Abby B, COHEN, Emil I, CHRISTOS, Paul, MAZUMDAR, Madhu, POPA, Elizabeta, BROWN, Robert S, RAFII, Shahin, SCHWARTZ, Jonathan D, OCEAN, Allyson, LEHRER, Deborah, GOLDENBERG, Alec, KNOX, Jennifer J, CHEN, Helen, CLARK-GARVEY, Sean, WEINBERG, Alan, MANDELI, John

Volltext

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced... von Thomas, Melanie B., Garrett-Mayer, Elizabeth, Anis, Munazza, Anderton, Kate, Bentz, Tricia, Edwards, Andie, Brisendine, Alan, Weiss, Geoffrey, Siegel, Abby B., Bendell, Johanna, Baron, Ari, Duddalwar, Vinay, El-Khoueiry, Anthony

Volltext

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial von Merle, Philippe, Kudo, Masatoshi, Edeline, Julien, Bouattour, Mohamed, Cheng, Ann-Lii, Chan, Stephen Lam, Yau, Thomas, Garrido, Marcelo, Knox, Jennifer, Daniele, Bruno, Breder, Valeriy, Lim, Ho Yeong, Ogasawara, Sadahisa, Cattan, Stéphane, Chao, Yee, Siegel, Abby B., Martinez-Forero, Iván, Wei, Ziwen, Liu, Chih-Chin, Finn, Richard S.

Volltext

Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips von Shen, Jing, Wang, Shuang, Zhang, Yu-Jing, Wu, Hui-Chen, Kibriya, Muhammad G., Jasmine, Farzana, Ahsan, Habibul, Wu, David PH, Siegel, Abby B., Remotti, Helen, Santella, Regina M.

Volltext

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial von Finn, Richard S, Ryoo, Baek-Yeol, Merle, Philippe, Kudo, Masatoshi, Bouattour, Mohamed, Lim, Ho Yeong, Breder, Valeriy, Edeline, Julien, Chao, Yee, Ogasawara, Sadahisa, Yau, Thomas, Garrido, Marcelo, Chan, Stephen L, Knox, Jennifer, Daniele, Bruno, Ebbinghaus, Scot W, Chen, Erluo, Siegel, Abby B, Zhu, Andrew X, Cheng, Ann-Lii

Volltext

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial von Kudo, Masatoshi, Lim, Ho Yeong, Cheng, Ann-Lii, Chao, Yee, Yau, Thomas, Ogasawara, Sadahisa, Kurosaki, Masayuki, Morimoto, Naoki, Ohkawa, Kazuyoshi, Yamashita, Tatsuya, Lee, Kyung-Hun, Chen, Erluo, Siegel, Abby B., Ryoo, Baek-Yeol

Volltext

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma von Finn, Richard S, Ikeda, Masafumi, Zhu, Andrew X, Sung, Max W, Baron, Ari D, Kudo, Masatoshi, Okusaka, Takuji, Kobayashi, Masahiro, Kumada, Hiromitsu, Kaneko, Shuichi, Pracht, Marc, Mamontov, Konstantin, Meyer, Tim, Kubota, Tomoki, Dutcus, Corina E, Saito, Kenichi, Siegel, Abby B, Dubrovsky, Leonid, Mody, Kalgi, Llovet, Josep M

Volltext

Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation von SIEGEL, Abby B, LIM, Emerson A, HALAZUN, Karim, DOVE, Lorna, BROWN, Robert S, NEUGUT, Alfred I, KATO, Tomoaki, REMOTTI, Helen, COPPLESON, Yael J, EMOND, Jean C, SHUANG WANG, BRUBAKER, William, RODRIGUEZ, Rosa D, GOYAL, Abhishek, JACOBSON, Judith S, HERSHMAN, Dawn L, VERNA, Elizabeth C, ZARETSKY, Jonah

Volltext

Metabolic Syndrome and Hepatocellular Carcinoma: Two Growing Epidemics With a Potential Link von SIEGEL, Abby B, ZHU, Andrew X

Volltext

Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial von Qin, Shukui, Chen, Zhendong, Fang, Weijia, Ren, Zhenggang, Xu, Ruocai, Ryoo, Baek-Yeol, Meng, Zhiqiang, Bai, Yuxian, Chen, Xiaoming, Liu, Xiufeng, Xiao, Juxiang, Ho, Gwo Fuang, Mao, Yimin, Wang, Xin, Ying, Jieer, Li, Jianfeng, Zhong, Wenyan, Zhou, Yu, Siegel, Abby B, Hao, Chunyi

Volltext

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial von Zhu, Andrew X, Finn, Richard S, Edeline, Julien, Cattan, Stephane, Ogasawara, Sadahisa, Palmer, Daniel, Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen L, Knox, Jennifer, Daniele, Bruno, Webber, Andrea L, Ebbinghaus, Scot W, Ma, Junshui, Siegel, Abby B, Cheng, Ann-Lii, Kudo, Masatoshi, Alistar, Angela, Asselah, Jamil, Blanc, Jean-Frederic, Borbath, Ivan, Cannon, Timothy, Chung, Ki, Cohn, Allen, Cosgrove, David P, Damjanov, Nevena, Gupta, Mukul, Karino, Yoshivasu, Karwal, Mark, Kaubisch, Andreas, Kelley, Robin, Van Laethem, Jena-Luc, Larson, Timothy, Lee, James, Li, Daneng, Manhas, Atisha, Manji, Gulam Abbas, Numata, Kazushi, Parsons, Benjamin, Paulson, Andrew S., Pinto, Carmine, Ramirez, Robert, Ratnam, Suresh, Rizell, Magnus, Rosmorduc, Olivier, Sada, Yvonne, Sasaki, Yutaka, Stal, Per I, Strasser, Simone, Trojan, Joerg, Vaccaro, Gina, Van Vlierberghe, Hans, Weiss, Alan, Weiss, Karl-Heinz, Yamashita, Tatsuya

Volltext

Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib von Kudo, Masatoshi, Finn, Richard S., Edeline, Julien, Cattan, Stéphane, Ogasawara, Sadahisa, Palmer, Daniel H., Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen L., Knox, Jennifer, Daniele, Bruno, Yau, Thomas, Gurary, Ellen B., Siegel, Abby B., Wang, Anran, Cheng, Ann-Lii, Zhu, Andrew X.

Volltext

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial von Verset, Gontran, Borbath, Ivan, Karwal, Mark, Verslype, Chris, Van Vlierberghe, Hans, Kardosh, Adel, Zagonel, Vittorina, Stal, Per, Sarker, Debashis, Palmer, Daniel H, Vogel, Arndt, Edeline, Julien, Cattan, Stephane, Kudo, Masatoshi, Cheng, Ann-Lii, Ogasawara, Sadahisa, Daniele, Bruno, Chan, Stephen L, Knox, Jennifer J, Qin, Shukui, Siegel, Abby B, Chisamore, Michael, Hatogai, Ken, Wang, Anran, Finn, Richard S, Zhu, Andrew X

Volltext

Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Cur... von Llovet, Josep M., Vogel, Arndt, Madoff, David C., Finn, Richard S., Ogasawara, Sadahisa, Ren, Zhenggang, Mody, Kalgi, Li, Jerry J., Siegel, Abby B., Dubrovsky, Leonid, Kudo, Masatoshi

Volltext

Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis von Santella, Regina M., Wang, Qiao, Remotti, Helen, Siegel, Abby B., Wang, Shuang, Shen, Jing, Sirosh, Iryna

Volltext

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis von Salomao, Marcela, Remotti, Helen, Vaughan, Roger, Siegel, Abby B, Lefkowitch, Jay H, Moreira, Roger Klein

Volltext